Authors
Mikhail Tsymliakov, Maria Hanl, Jana Enns, Shiyang Zhai, Eleonora Ferretti, Philipp König, Rama Kousa, Jia-Wey Tu, Christian Steinebach, Michael Gütschow, Gerd Bendas, Sanil Bhatia, Günther Weindl, Finn K Hansen
Published in
Journal of medicinal chemistry. Volume 69. Issue 17. Pages 21018-21043. Sep 10, 2026.
Abstract
This work reports on the development of selective histone deacetylase 6 (HDAC6) degraders based on a peptoid scaffold. Structure-based design identified the isocyanide-derived cap region as suitable exit vector for linker attachment, enabling rapid generation of CRBN-recruiting PROTACs via the Ugi four-component reaction. A focused library of 12 degraders revealed a strong dependence of activity on linker composition, with octyl-linked compounds (9e-h) showing the strongest HDAC6 degradation with half-maximal degradation values of 17-36 nM in kinetic HDAC6 degradation assays. The lead compounds selectively degraded HDAC6 in MM.1S and MV4-11 cells without affecting class I HDACs and demonstrated clean proteomic profiles. Functionally, compounds 9e and 9f displayed submicromolar antiproliferative activity against FLT3-ITD-mutated acute myeloid leukemia cells and suppressed proinflammatory signaling in immune cells. Both effects were associated in part with residual class I HDAC inhibition. Overall, this study establishes an efficient multicomponent strategy for PROTAC synthesis and highlights key structure-degradation relationships.
PMID:
42720482
Bibliographic data and abstract were imported from PubMed on 10 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0